Clinical Trials Browser

Withdrawn × Interventional × Liver Diseases × Clear all

NCT05084456 2021-10-19

Oral Docetaxel in Patients With Normal or Impaired Liver Function

Phase 1 Withdrawn

Liver Diseases

NCT02989870 2020-06-05

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

Phase 1 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms